MCK as of Oct 31 · 11:31 ET

MCKNYSEWholesale-Drugs, Proprietaries & Druggists' Sundries

McKesson Corp · Brief

Next report

3 days

Nov 3 · after closeest.Q2 FY27

Earnings

Expected move

Inputs

±5.7%implied · report alone

938.211,050.95

straddle ±7.0%

spot 994.58exp Nov 20ATM strike 990ATM straddle 81.65IV 43%

Oct 30 closereport share · term structure

Expected move

Inputs

Implied vs realized

8 reportsHistory

2 of 8≥ implied

avg implied: ±4.4%
avg realized: ±3.6%

Feb 5 '25±4.7%▼−1.18%×0.25

May 8 '25±4.4%▲+0.47%×0.11

Aug 6 '25±3.9%▼−5.76%×1.48

Q2 FY26±1.7%▼−0.30%×0.18

Nov 5 '25±3.4%▲+1.70%×0.50

Q3 FY26±4.5%▲+16.52%×3.70

Q4 FY26±6.1%▼−2.47%×0.40

Q1 FY27±6.2%▼−0.67%×0.11

quarterimplied−20%0+20%realized×

Q1 FY27±6.2%▼−0.67%×0.11

Q4 FY26±6.1%▼−2.47%×0.40

Q3 FY26±4.5%▲+16.52%×3.70

Nov '25±3.4%▲+1.70%×0.50

Q2 FY26±1.7%▼−0.30%×0.18

Aug '25±3.9%▼−5.76%×1.48

2 older reports

May '25±4.4%▲+0.47%×0.11

Feb '25±4.7%▼−1.18%×0.25

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 3 report · est.

Bull2 of 4

2,028managers reporting a position in the latest quarterly filings13F · Jun 30 '26

11tracked funds holding MCKN-PORT · Aug 31 '26

Bear2 of 4

73.00%revenue from the largest disclosed customer among ten largest combinedSEC filings

31.00%of Pacira BioSciences Inc.'s revenue is MCK per their filingSEC filings

AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

MCK report session

Suppliers 1

GILDGilead Sciences×0.26

× = co-movement · max 501dSource: SEC filings · market data

Latest changes

30 daysAll changes

Oct 20impliedImplied move: ±6.9% into Nov 3 earnings (Oct 20 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.